Catalog No.
YVV03303
Expression system
E. coli
Species
Influenza B virus (strain B/Lee/1940)
Protein length
Met1-Tyr560
Predicted molecular weight
63.93 kDa
Nature
Recombinant
Applications
ELISA, Immunogen, SDS-PAGE, WB, Bioactivity testing in progress
Endotoxin level
Please contact with the lab for this information.
Purity
>90% as determined by SDS-PAGE.
Accession
P04665
Form
Lyophilized
Storage buffer
Lyophilized from a solution in PBS pH 7.4, 0.02% NLS, 1mM EDTA, 4% Trehalose, 1% Mannitol.
Reconstitution
Reconstitute in sterile water for a stock solution. A copy of datasheet will be provided with the products, please refer to it for details.
Shipping
In general, proteins are provided as lyophilized powder/frozen liquid. They are shipped out with dry ice/blue ice unless customers require otherwise.
Stability and Storage
Use a manual defrost freezer and avoid repeated freeze thaw cycles. Store at 2 to 8°C for one week. Store at -20 to -80°C for twelve months from the date of receipt.
Alternative Names
Nucleoprotein, Nucleocapsid protein, Protein N, NP
Note
For research use only.
Mapping the phosphoproteome of influenza A and B viruses by mass spectrometry., PMID:23144613
[Analysis of genetic variation of hemagglutinin and three internal genes of influenza B virus isolated in Zhejiang province from 1999 to 2012]., PMID:23958122
Influenza B virus has global ordered RNA structure in (+) and (-) strands but relatively less stable predicted RNA folding free energy than allowed by the encoded protein sequence., PMID:23958134
Nucleoprotein of influenza B virus binds to its type A counterpart and disrupts influenza A viral polymerase complex formation., PMID:24309113
The N terminus of the influenza B virus nucleoprotein is essential for virus viability, nuclear localization, and optimal transcription and replication of the viral genome., PMID:25122787
Nuclear localized Influenza nucleoprotein N-terminal deletion mutant is deficient in functional vRNP formation., PMID:25174360
Development of high yield reassortants for influenza type B viruses and analysis of their gene compositions., PMID:25545595
Molecular epidemiology and phylogenetic analyses of influenza B virus in Thailand during 2010 to 2014., PMID:25602617
Phosphorylation at the homotypic interface regulates nucleoprotein oligomerization and assembly of the influenza virus replication machinery., PMID:25867750
Progress on adenovirus-vectored universal influenza vaccines., PMID:25876176
The Functional Study of the N-Terminal Region of Influenza B Virus Nucleoprotein., PMID:26368391
RIG-I Signaling Is Essential for Influenza B Virus-Induced Rapid Interferon Gene Expression., PMID:26378160
Cold adaptation generates mutations associated with the growth of influenza B vaccine viruses., PMID:26407922
New capillary gel electrophoresis method for fast and accurate identification and quantification of multiple viral proteins in influenza vaccines., PMID:26452923
Mouse adaptation of influenza B virus increases replication in the upper respiratory tract and results in droplet transmissibility in ferrets., PMID:26526113
Adaptation of H9N2 AIV in guinea pigs enables efficient transmission by direct contact and inefficient transmission by respiratory droplets., PMID:26552719
A natural component from Euphorbia humifusa Willd displays novel, broad-spectrum anti-influenza activity by blocking nuclear export of viral ribonucleoprotein., PMID:26850850
Current and novel antiviral strategies for influenza infection., PMID:27344481
Antiviral activity of KR-23502 targeting nuclear export of influenza B virus ribonucleoproteins., PMID:27565992
Influenza B virus non-structural protein 1 counteracts ISG15 antiviral activity by sequestering ISGylated viral proteins., PMID:27587337
Binding of RNA by the Nucleoproteins of Influenza Viruses A and B., PMID:27649229
Influenza in the Emergency Department., PMID:27681494
Whole-Genome Phylogenetic Analysis of Influenza B/Phuket/3073/2013-Like Viruses and Unique Reassortants Detected in Malaysia between 2012 and 2014., PMID:28129386
Molecular and biochemical characterization of the NS1 protein of non-cultured influenza B virus strains circulating in Singapore., PMID:28348873
Single nucleoprotein residue determines influenza A virus sensitivity to an intertypic suppression mechanism., PMID:28371631
Predominance of influenza A(H3N2) viruses during the 2016/2017 season in Bulgaria., PMID:29297852
Anti-influenza effect and action mechanisms of the chemical constituent gallocatechin-7-gallate from Pithecellobium clypearia Benth., PMID:29802302
Guava flavonoid glycosides prevent influenza A virus infection via rescue of P53 activity., PMID:30153335
Non-Uniform and Non-Random Binding of Nucleoprotein to Influenza A and B Viral RNA., PMID:30257455
Optimized Expression, Purification, and Rapid Detection of Recombinant Influenza Nucleoproteins Expressed in Sf9 Insect Cells., PMID:30441884
Single mucosal vaccination targeting nucleoprotein provides broad protection against two lineages of influenza B virus., PMID:30639307
The Extended C-Terminal Region of Influenza C Virus Nucleoprotein Is Important for Nuclear Import and Ribonucleoprotein Activity., PMID:30814281
Identification of NMS-873, an allosteric and specific p97 inhibitor, as a broad antiviral against both influenza A and B viruses., PMID:30930289
Naproxen Exhibits Broad Anti-influenza Virus Activity in Mice by Impeding Viral Nucleoprotein Nuclear Export., PMID:31067470
Development of Replication Protein A-Conjugated Gold Nanoparticles for Highly Sensitive Detection of Disease Biomarkers., PMID:31269392
A systems biology-driven approach to construct a comprehensive protein interaction network of influenza A virus with its host., PMID:32631335
Hsa-miR-30e-3p inhibits influenza B virus replication by targeting viral NA and NP genes., PMID:32878461
Isolation of Antibodies Against the Spike Protein of SARS-CoV from Pig Serum for Competitive Immunoassay., PMID:34466204
Development of a pentavalent broadly protective nucleoside-modified mRNA vaccine against influenza B viruses., PMID:35945226
Immunogenicity, reactogenicity and safety of an inactivated quadrivalent influenza vaccine in children and adolescents 6 months through 17 years of age in India., PMID:36053721
A Multiseason Randomized Controlled Trial of Advax-Adjuvanted Seasonal Influenza Vaccine in Participants With Chronic Disease or Older Age., PMID:38157402
CD8+ T-cell responses towards conserved influenza B virus epitopes across anatomical sites and age., PMID:38684663
Genetic Reassortment in a Child Coinfected with Two Influenza B Viruses, B/Yamagata Lineage and B/Victoria-Lineage Strains., PMID:38932274
Synthesis and anti-influenza virus activity of substituted dibenzoxepine-based baloxavir derivatives., PMID:39388905
Discovery of Novel Thiophene-Based Baloxavir Derivatives as Potent Cap-Dependent Endonuclease Inhibitors for Influenza Treatment., PMID:39658517
A novel tetravalent influenza vaccine based on one chimpanzee adenoviral vector., PMID:40023902
Novel benzamide derivatives with indole moiety as dual-target antiviral agents: Rational design, efficient synthesis, and potent anti-influenza activity through concurrent binding to PAC terminal domain and viral nucleoprotein., PMID:40367674
Antigenic Characterization of H1N1 Influenza Viruses That Circulated During the 2019-2020 Season in Philadelphia, Pennsylvania., PMID:40452165
Host factor Rab4b promotes the replication of influenza A virus., PMID:40453470
Lycorine Inhibits Influenza Virus Replication by Affecting Nascent Nucleoporin Nup93 Synthesis., PMID:40508167
For research use only. Not for human or drug use.
